Reuters: Abbott's TriLipix improves cholesterol long term

[NaDiNe]

Abbott's TriLipix improves cholesterol long term
      

NEW ORLEANS (Reuters) - Abbott Laboratories Inc's experimental drug TriLipix was able to significantly improve cholesterol and triglyceride levels in patients for another year following earlier three-month trials, researchers said on Tuesday.</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login